Please login to the form below

Not currently logged in
Email:
Password:

Lighthouse bolsters its US senior scientific team

Marc Pondel joins the agency as executive medical science director

Lighthouse Medical Communications US, part of the Lucid Group companies, has appointed Marc Pondel as its executive medical science director.

Pondel’s new role will see him guide the Lighthouse medical writing teams as he brings scientific and clinical strategic insight knowledge for the agency’s clients.

Andy Willmer, managing director of Lighthouse, said: “As Lighthouse expands its footprint in the USA we must ensure we build a platform of scientific capability that can continually deliver magical programmes for our clients.

“Dr Pondel brings not only a background of scientific excellence but a rich experience of creative communication approaches, which can truly impact patient outcomes.”

Pondel’s career has seen him serve in various senior-level strategic medical and advisory positions, leading teams in a number of key therapeutic areas.

He said: “The Lighthouse team is superbly capable and I look forward to helping them elevate our work in the dynamic US marketplace.

“Our shared passion for developing great medical communications programmes that help to change behaviour and improve outcomes is truly special.”

19th March 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics